Screening Guideline for Cervical Cancer Recommends Against Human Papillomavirus–Pap Cotesting

The U.S. Preventive Services Task Force's new draft guideline now recommends that women aged 30–65 years get tested for high-risk genotypes of human papillomavirus (hrHPV) every 5 years or get a Pap screening every 3 years. That is a major change from the task force's 2012 recommendation of cotesting: screening with the hrHPV test plus Pap screening every 5 years for women in that age group (Ann. Intern. Med. 2012;156:880–91; doi:10.7326/0003-4819-156-12-201206190-00424). A final guideline will be published after a period of public comment.

http://ift.tt/2mtgTaZ